A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., Neuman, B. W., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-0695-z · Cited by 8,436 · see citing works

Origin and evolution of pathogenic coronaviruses

Cui, J., Li, F., & Shi, Z. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,543 · see citing works

The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak

Chinazzi, M., Davis, J. T., Ajelli, M., Gioannini, C., Litvinova, M., Merler, S., Pastore y Piontti, A., Mu, K., Rossi, L., Sun, K., et al. (2020) · Science · doi:10.1126/science.aba9757 · Cited by 3,694 · see citing works

Early dynamics of transmission and control of COVID-19: a mathematical modelling study

Kucharski, A. J., Russell, T., Diamond, C., Liu, Y., Edmunds, J., Funk, S., Eggo, R. M., Sun, F., Jit, M., Munday, J. D., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30144-4 · Cited by 2,675 · see citing works

Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

Kissler, S. M., Tedijanto, C., Goldstein, E., Grad, Y. H., & Lipsitch, M. (2020) · Science · doi:10.1126/science.abb5793 · Cited by 2,611 · see citing works

Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019

Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa344 · Cited by 2,607 · see citing works

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375 · see citing works

The COVID-19 vaccine development landscape

Le, T. T., Andreadakis, Z., Kumar, A., Román, R. G., Tollefsen, S., Saville, M. K., & Mayhew, S. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00073-5 · Cited by 1,959 · see citing works

Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes

Zhang, W., Du, R., Li, B., Zheng, X.-S., Yang, X., Hu, B., Wang, Y., Xiao, G., Yan, B., Shi, Z., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1729071 · Cited by 1,800 · see citing works

COVID-19: immunopathology and its implications for therapy

Cao, X. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0308-3 · Cited by 1,609 · see citing works

Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China

Wu, J. T. K., Leung, K. S. M., Bushman, M., Kishore, N., Niehus, R., Salazar, P. M. D., Cowling, B. J., Lipsitch, M., & Leung, G. M. (2020) · Nature Medicine · doi:10.1038/s41591-020-0822-7 · Cited by 1,308 · see citing works

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

Tian, X., Li, C., Huang, A., Xia, S., Lu, S., Shi, Z., Lu, L., Jiang, S., Yang, Z., Wu, Y., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1729069 · Cited by 1,239 · see citing works

Antibody-dependent enhancement of severe dengue disease in humans

Katzelnick, L. C., Gresh, L., Halloran, M. E., Mercado, J. C., Kuan, G. M., Gordon, A. L., Balmaseda, Á., & Harris, E. (2017) · Science · doi:10.1126/science.aan6836 · Cited by 1,202 · see citing works

Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictionsPreprint

Read, J. M., Bridgen, J. R. E., Cummings, D. A. T., et al. (2020) · medRxiv · doi:10.1101/2020.01.23.20018549 · Cited by 951 · see citing works

A Sequence Homology and Bioinformatic Approach Can Predict Candidate Targets for Immune Responses to SARS-CoV-2

Grifoni, A., Sidney, J., Zhang, Y., Scheuermann, R. H., Peters, B., & Sette, A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.03.002 · Cited by 920 · see citing works

Evidence for Camel-to-Human Transmission of MERS Coronavirus

Azhar, E. I., El-Kafrawy, S. A., Farraj, S. A., Hassan, A. M., Al-Saeed, M. S., Hashem, A. M., & Madani, T. A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401505 · Cited by 907 · see citing works

The convalescent sera option for containing COVID-19

Casadevall, A., & Pirofski, L. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138003 · Cited by 904 · see citing works

Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses

Jiang, S., Hillyer, C., & Du, L. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.03.007 · Cited by 847 · see citing works

Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools

Fu, Y., Cheng, Y., & Wu, Y. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00207-4 · Cited by 798 · see citing works

Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy

Sridhar, S., Luedtke, A. R., Langevin, E., Zhu, M., Bonaparte, M. I., Machabert, T., Savarino, S. J., Zambrano, B., Moureau, A., Khromava, A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800820 · Cited by 792 · see citing works

Epidemiology and Clinical Presentations of the Four Human Coronaviruses 229E, HKU1, NL63, and OC43 Detected over 3 Years Using a Novel Multiplex Real-Time PCR Method

Gaunt, E. R., Hardie, A., Claas, E. C. J., Peter Simmonds, K., & Templeton, K. E. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.00636-10 · Cited by 699 · see citing works

Cultivation of a Novel Type of Common-cold Virus in Organ Cultures

Tyrrell, D. A. J., & Bynoe, M. L. (1965) · BMJ · doi:10.1136/bmj.1.5448.1467 · Cited by 623 · see citing works

The time course of the immune response to experimental coronavirus infection of man

Callow, K. A., Parry, H. F., Sergeant, M., & Tyrrell, D. A. J. (1990) · Epidemiology and Infection · doi:10.1017/s0950268800048019 · Cited by 598 · see citing works

Evidence That Maternal Dengue Antibodies Are Important in the Development of Dengue Hemorrhagic Fever in Infants

Kliks, S. C., Nimmanitya, S., Nisalak, A., & Burke, D. S. (1988) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1988.38.411 · Cited by 577 · see citing works

Immunopathogenesis of coronavirus infections: implications for SARS

Dandekar, A. A., & Perlman, S. M. (2005) · Nature reviews. Immunology · doi:10.1038/nri1732 · Cited by 499 · see citing works

Lack of Peripheral Memory B Cell Responses in Recovered Patients with Severe Acute Respiratory Syndrome: A Six-Year Follow-Up Study

Tang, F., Quan, Y., Xin, Z.-T., Wrammert, J., Ma, M.-J., Lv, H., Wang, T.-B., Yang, H., Richardus, J. H., Liu, W., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0903490 · Cited by 496 · see citing works

Duration of Antibody Responses after Severe Acute Respiratory Syndrome

Wu, L.-P., Wang, N.-C., Chang, Y.-H., Tian, X.-Y., Na, D.-Y., Zhang, L.-Y., Zheng, L., Lan, T., Wang, L.-F., & Liang, G.-D. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1310.070576 · Cited by 426 · see citing works

Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins

Wang, S., Tseng, S., Yen, C., Yang, J.-Y., Tsao, C.-H., Shen, C.-W., Chen, K.-H., Liu, F., Liu, W.-T., Chen, Y. A., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.090 · Cited by 421 · see citing works

Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice

Bisht, H., Roberts, A., Vogel, L., Bukreyev, A. A., Collins, P. L., Murphy, B. R., Subbarao, K., & Moss, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401939101 · Cited by 415 · see citing works

Serological assays for emerging coronaviruses: Challenges and pitfalls

Meyer, B., Drosten, C., & Müller, M. A. (2014) · Virus Research · doi:10.1016/j.virusres.2014.03.018 · Cited by 405 · see citing works

Human immunopathogenesis of severe acute respiratory syndrome (SARS)

Cameron, M. J., Bermejo-Martin, J. F., Danesh, A., Muller, M. P., & Kelvin, D. J. (2008) · Virus Research · doi:10.1016/j.virusres.2007.02.014 · Cited by 391 · see citing works

Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection

Corman, V. M., Albarrak, A. M., Omrani, A. S., Albarrak, M. M., Farah, M. E., Almasri, M. M., Muth, D., Sieberg, A., Meyer, B., Assiri, A. M., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ951 · Cited by 370 · see citing works

Disappearance of Antibodies to SARS-Associated Coronavirus after Recovery

Cao, W.-C., Liu, W., Zhang, P.-H., Zhang, F., & Richardus, J. H. (2007) · New England Journal of Medicine · doi:10.1056/nejmc070348 · Cited by 367 · see citing works

Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study

Müller, M. A., Meyer, B., Corman, V. M., Almasri, M. M., Turkestani, A., Ritz, D., Sieberg, A., Aldabbagh, S., Bosch, B., Lattwein, E., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)70090-3 · Cited by 316 · see citing works

Anti-Severe Acute Respiratory Syndrome Coronavirus Spike Antibodies Trigger Infection of Human Immune Cells via a pH- and Cysteine Protease-Independent FcγR Pathway

Jaume, M., Yip, M., Cheung, C. Y., Leung, N., Li, P. H., Kien, F., Dutry, I., Callendret, B., Escriou, N., Altmeyer, R. M., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00671-11 · Cited by 312 · see citing works

Effects of a "new" human respiratory virus in volunteers.

Bradburne, A. F., Bynoe, M. L., & Tyrrell, D. A. J. (1967) · BMJ · doi:10.1136/bmj.3.5568.767 · Cited by 304 · see citing works

Viral Kinetics and Antibody Responses in Patients with COVID-19Preprint

Tan, W., Lu, Y., Zhang, J., Wang, J., Dan, Y., Tan, Z., He, X., Qian, C., Sun, Q., Hu, Q., et al. (2020) · medRxiv · doi:10.1101/2020.03.24.20042382 · Cited by 303 · see citing works

Countering the Zika epidemic in Latin America

Ferguson, N. M., Cucunubá, Z. M., Dorigatti, I., Nedjati-Gilani, G. L., Donnelly, C. A., Basáñez, M.-G., Nouvellet, P., & Lessler, J. (2016) · Science · doi:10.1126/science.aag0219 · Cited by 296 · see citing works

Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies

Zhu, Z., Chakraborti, S., He, Y., Roberts, A., Sheahan, T., Xiao, X., Hensley, L. E., Prabakaran, P., Rockx, B., Sidorov, I. A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701000104 · Cited by 284 · see citing works

Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure

Eyal, N., Lipsitch, M., & Smith, P. G. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa152 · Cited by 283 · see citing works

Two‐Year Prospective Study of the Humoral Immune Response of Patients with Severe Acute Respiratory Syndrome

Liu, W. Y., Fontanet, A. L., Zhang, P., Zhan, L., Xin, Z., Baril, L., Tang, F., Lv, H., & Cao, W. (2006) · The Journal of Infectious Diseases · doi:10.1086/500469 · Cited by 282 · see citing works

Reconstruction of antibody dynamics and infection histories to evaluate dengue risk

Salje, H., Cummings, D. A. T., Rodríguez-Barraquer, I., Katzelnick, L. C., Lessler, J., Klungthong, C., Thaisomboonsuk, B., Nisalak, A., Weg, A. L., Ellison, D. W., et al. (2018) · Nature · doi:10.1038/s41586-018-0157-4 · Cited by 261 · see citing works

Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus

Hsueh, P., Huang, L., Chen, P., Kao, C., & Yang, P. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01009.x · Cited by 255 · see citing works

Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses

Yang, Z., Werner, H. C., Kong, W., Leung, K., Traggiai, E., Lanzavecchia, A., & Nabel, G. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409065102 · Cited by 250 · see citing works

Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus

Yip, M., Leung, N., Cheung, C. Y., Li, P. H., Lee, H. H. Y., Daëron, M., Peiris, M. J. S., Bruzzone, R., & Jaume, M. (2014) · Virology Journal · doi:10.1186/1743-422x-11-82 · Cited by 249 · see citing works

Antibody-mediated enhancement of disease in feline infectious peritonitis: Comparisons with dengue hemorrhagic fever

Weiss, R. C., & Scott, F. W. (1981) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/0147-9571(81)90003-5 · Cited by 242 · see citing works

Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment

Ferguson, N. M., Rodríguez-Barraquer, I., Dorigatti, I., et al. (2016) · Science · doi:10.1126/science.aaf9590 · Cited by 242 · see citing works

MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015

Choe, P. G., Perera, R. A. P. M., Park, W. B., Song, K.-H., Bang, J. H., Kim, E. S., Kim, H. B., Ko, L. W. R., Park, S. W., Kim, N.-J., et al. (2017) · Emerging Infectious Diseases · doi:10.3201/eid2307.170310 · Cited by 227 · see citing works

Rhinovirus and Coronavirus Infection–Associated Hospitalizations among Older Adults

Falsey, A. R., Walsh, E. E., & Hayden, F. G. (2002) · The Journal of Infectious Diseases · doi:10.1086/339881 · Cited by 194 · see citing works

The dominance of human coronavirus OC43 and NL63 infections in infants

Dijkman, R., Jebbink, M. F., Gaunt, E. R., Rossen, J. W. A., Templeton, K. E., Kuijpers, T. W., & van der Hoek, L. (2011) · Journal of Clinical Virology · doi:10.1016/j.jcv.2011.11.011 · Cited by 189 · see citing works

Longitudinal profile of antibodies against SARS‐coronavirus in SARS patients and their clinical significance

Mo, H.-Y., Zeng, G., Ren, X., Li, H., Ke, C., Tan, Y.-X., Chaoda, C. A. I., Lai, K., Chen, R., Chan‐Yeung, M., et al. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00783.x · Cited by 188 · see citing works

Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals

Zhang, L., Zhang, F., Yu, W., Tian, H., Yu, J., Yi, C. E., Ba, L., Li, W., Farzan, M., Chen, Z., et al. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20499 · Cited by 184 · see citing works

Clinical Impact of Human Coronaviruses 229E and OC43 Infection in Diverse Adult Populations

Walsh, E. E., Shin, J. H., & Falsey, A. R. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit393 · Cited by 184 · see citing works

Human Coronavirus NL63 and 229E Seroconversion in Children

Dijkman, R., Jebbink, M. F., Idrissi, N. B. E., Pyrć, K., Müller, M. A., Kuijpers, T. W., Zaaijer, H. L., & van der Hoek, L. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00533-08 · Cited by 177 · see citing works

Longitudinal Profile of Immunoglobulin G (IgG), IgM, and IgA Antibodies against the Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein in Patients with Pneumonia Due to the SARS Coronavirus

Woo, P. C. Y., Lau, S. K. P., Wong, B. H. L., Chan, K., Chu, C., Tsoi, H.-W., Huang, Y. P., Peiris, M. J. S., & Yuen, K. (2004) · Clinical and Vaccine Immunology · doi:10.1128/cdli.11.4.665-668.2004 · Cited by 177 · see citing works

Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing

Elshabrawy, H. A., Coughlin, M. M., Baker, S. C., & Prabhakar, B. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050366 · Cited by 173 · see citing works

Antigenic Cross‐Reactivity between Severe Acute Respiratory Syndrome–Associated Coronavirus and Human Coronaviruses 229E and OC43

Che, X., Qiu, L., Liao, Z., Wang, Y., Wen, K., Pan, Y., Hao, W., Mei, Y., Cheng, V. C., & Yuen, K. (2005) · The Journal of Infectious Diseases · doi:10.1086/430355 · Cited by 165 · see citing works

Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests

Chan, K., Chan, J. F., Tse, H., Chen, H., Lau, C. C.-Y., Cai, J., Tsang, A. K. L., Xiao, X., To, K. K., Lau, S. K. P., et al. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.03.015 · Cited by 157 · see citing works

An Outbreak of Human Coronavirus OC43 Infection and Serological Cross‐Reactivity with SARS Coronavirus

Patrick, D. M., Petric, M., Skowronski, D. M., Guasparini, R., Booth, T. F., Krajden, M., McGeer, P. L., Bastien, N., Gustafson, L., Dubord, J., et al. (2006) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2006/152612 · Cited by 152 · see citing works

Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea

Park, W. B., Perera, R. A. P. M., Choe, P. G., Lau, E. H. Y., Choi, S. J., Chun, J. Y., Oh, H. S., Song, K., Bang, J. H., Kim, E. S., et al. (2015) · Emerging infectious diseases · doi:10.3201/eid2112.151421 · Cited by 150 · see citing works

The behaviour of recent isolates of human respiratory coronavirus in vitro and in volunteers: evidence of heterogeneity among 229E-related strains

Reed, S. E. (1984) · Journal of Medical Virology · doi:10.1002/jmv.1890130208 · Cited by 147 · see citing works

Neutralizing Antibodies in Patients with Severe Acute Respiratory Syndrome-Associated Coronavirus Infection

Nie, Y., Wang, G., Shi, X., Zhang, H., Yan, Q., Zhong-ping, H., Wei, W., Lian, G., Yin, X., Du, L., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/423286 · Cited by 146 · see citing works

The Tecumseh Study of Respiratory Illness. VI. Frequency of and Relationship between Outbreaks of Coronavims Infection

Monto, A. S., & Lim, S. (1974) · The Journal of Infectious Diseases · doi:10.1093/infdis/129.3.271 · Cited by 146 · see citing works

Isolation and Propagation of a Human Enteric Coronavirus

Resta, S. C., Luby, J. P., Rosenfeld, C. R., & Siegel, J. D. (1985) · Science · doi:10.1126/science.2992091 · Cited by 144 · see citing works

Antibody Response and Disease Severity in Healthcare Worker MERS Survivors

Alshukairi, A. N., Khalid, I., Ahmed, W., Dada, A. M., Bayumi, D. T., Malic, L. S., Althawadi, S., Ignacio, K. H., Alsalmi, H., Al-Abdely, H. M., et al. (2016) · Emerging infectious diseases · doi:10.3201/eid2206.160010 · Cited by 139 · see citing works

Neutralizing Antibody Response and SARS Severity

Ho, M., Chen, W., Chen, H., Lin, S.-F., Wang, M.-C., Di, J., Lu, Y., Liu, C., Chang, S., Chao, C.-L., et al. (2005) · Emerging infectious diseases · doi:10.3201/eid1111.040659 · Cited by 138 · see citing works

Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus‐associated illnesses

Gorse, G. J., Donovan, M. M., & Patel, G. B. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25715 · Cited by 136 · see citing works

Structural Basis for Potent Cross-Neutralizing Human Monoclonal Antibody Protection against Lethal Human and Zoonotic Severe Acute Respiratory Syndrome Coronavirus Challenge

Rockx, B., Corti, D., Donaldson, E., Sheahan, T., Stadler, K., Lanzavecchia, A., & Baric, R. (2008) · Journal of Virology · doi:10.1128/jvi.02377-07 · Cited by 134 · see citing works

High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia

Alshukairi, A. N., Zheng, J. H., Zhao, J., Nehdi, A., Baharoon, S. A., Layqah, L. A., Bokhari, A. A., Johani, S. M. A., Samman, N., Boudjelal, M., et al. (2018) · mBio · doi:10.1128/mbio.01985-18 · Cited by 131 · see citing works

Seventy-five years of estimating the force of infection from current status data

Hens, N., Aerts, M., Faes, C., et al. (2009) · Epidemiology and Infection · doi:10.1017/s0950268809990781 · Cited by 127 · see citing works

First infection by all four non-severe acute respiratory syndrome human coronaviruses takes place during childhood

Zhou, W., Wang, W., Wang, H., Lu, R., & Tan, W. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-433 · Cited by 124 · see citing works

Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS.

Yip, M., Leung, N., Li, P. H., Cheung, C. Y., Dutry, I., Li, D., Daëron, M., Bruzzone, R., Peiris, M. J. S., & Jaume, M. (2016) · PubMed · Cited by 123 · see citing works

Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen

Spanakis, N., Tsiodras, S., Haagmans, B. L., Raj, V. S., Pontikis, K., Koutsoukou, A., Koulouris, N. G., Osterhaus, A. D. M. E., Koopmans, M., & Tsakris, A. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.07.026 · Cited by 123 · see citing works

Effect of specific humoral immunity and some non-specific factors on resistance of volunteers to respiratory coronavirus infection

Callow, K. A. (1985) · Journal of Hygiene · doi:10.1017/s0022172400062410 · Cited by 119 · see citing works

Cross-Neutralization of Human and Palm Civet Severe Acute Respiratory Syndrome Coronaviruses by Antibodies Targeting the Receptor-Binding Domain of Spike Protein

He, Y., Li, J., Li, W., Lustigman, S., Farzan, M., & Jiang, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6085 · Cited by 118 · see citing works

Serological Responses in Patients with Severe Acute Respiratory Syndrome Coronavirus Infection and Cross-Reactivity with Human Coronaviruses 229E, OC43, and NL63

Chan, K. H., Cheng, V. C., Woo, P. C. Y., Lau, S. K. P., Poon, L. L. M., Guan, Y., Seto, W., Yuen, K., & Peiris, M. J. S. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.11.1317-1321.2005 · Cited by 113 · see citing works

Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase

Xu, D., Zhang, Z., Jin, L., Chu, F., Mao, Y., Wang, H., Liu, M., Wang, M., Zhang, L., Gao, G. F., et al. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-1299-5 · Cited by 111 · see citing works

Evaluation of Serologic and Antigenic Relationships Between Middle Eastern Respiratory Syndrome Coronavirus and Other Coronaviruses to Develop Vaccine Platforms for the Rapid Response to Emerging Coronaviruses

Agnihothram, S., Gopal, R., Yount, B. L., Donaldson, E., Menachery, V. D., Graham, R. L., Scobey, T., Gralinski, L. E., Denison, M. R., Zambon, M. C. F. A., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit609 · Cited by 104 · see citing works

Development of a Nucleocapsid-Based Human Coronavirus Immunoassay and Estimates of Individuals Exposed to Coronavirus in a U.S. Metropolitan Population

Severance, E. G., Bossis, I., Dickerson, F., Stallings, C. R., Origoni, A. E., Sullens, A., Yolken, R. H., & Viscidi, R. P. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00124-08 · Cited by 101 · see citing works

Investigation of Anti-Middle East Respiratory Syndrome Antibodies in Blood Donors and Slaughterhouse Workers in Jeddah and Makkah, Saudi Arabia, Fall 2012

Aburizaiza, A. S., Mattes, F. M., Azhar, E. I., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit589 · Cited by 95 · see citing works

Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virus

Chan, C.-M., Tse, H., Wong, S. S. Y., Woo, P. C. Y., Lau, S. K. P., Chen, L., Zheng, B. J., Huang, J., & Yuen, K. (2009) · Journal of Clinical Virology · doi:10.1016/j.jcv.2009.02.011 · Cited by 92 · see citing works

Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups

Leung, G. M., Lim, W., Ho, L., et al. (2005) · Epidemiology and Infection · doi:10.1017/s0950268805004826 · Cited by 90 · see citing works

The Pediatric Burden of Human Coronaviruses Evaluated for Twenty Years

Talbot, H. K., Shepherd, B. E., Crowe, J. E., Griffin, M. R., Edwards, K. M., Podsiad, A. B., Tollefson, S. J., Wright, P. F., & Williams, J. V. (2009) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31819d0d27 · Cited by 89 · see citing works

B-Cell Responses in Patients Who Have Recovered from Severe Acute Respiratory Syndrome Target a Dominant Site in the S2 Domain of the Surface Spike Glycoprotein

Zhong, X., Yang, H., Guo, Z., Sin, W.-Y. F., Chen, W., Xu, J., Fu, L. L., Wu, J., Mak, C.-K. G., Cheng, C.-S. S., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3401-3408.2005 · Cited by 89 · see citing works

Antigenic relationships amongst coronaviruses

Bradburne, A. F. (1970) · Archives of Virology · doi:10.1007/bf01253769 · Cited by 87 · see citing works

Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants

Tai, W., Wang, Y., Fett, C., Zhao, G., Li, F., Perlman, S. M., Jiang, S., Zhou, Y., & Du, L. (2016) · Journal of Virology · doi:10.1128/jvi.01651-16 · Cited by 85 · see citing works

Identification of Immunodominant Epitopes on the Membrane Protein of the Severe Acute Respiratory Syndrome-Associated Coronavirus

He, Y., Zhou, Y., Siddiqui, P., Niu, J., & Jiang, S. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.8.3718-3726.2005 · Cited by 84 · see citing works

Middle East Respiratory Syndrome Coronavirus Infection Dynamics and Antibody Responses among Clinically Diverse Patients, Saudi Arabia

Al-Abdely, H. M., Midgley, C. M., Alkhamis, A. M., Abedi, G. R., Lu, X., Binder, A. M., Alanazi, K. H., Tamin, A., Banjar, W. M., Lester, S. N., et al. (2019) · Emerging infectious diseases · doi:10.3201/eid2504.181595 · Cited by 81 · see citing works

Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections

Okba, N. M. A., Raj, V. S., Widjaja, I., GeurtsvanKessel, C. H., de Bruin, E., Chandler, F. D., Park, W. B., Kim, N. J., Farag, E., Al-Hajri, M., et al. (2019) · Emerging infectious diseases · doi:10.3201/eid2510.190051 · Cited by 79 · see citing works

Serologic responses of 42 MERS-coronavirus-infected patients according to the disease severity

Ko, J., Müller, M. A., Seok, H., Park, G. E., Lee, J. Y., Cho, S. Y., Ha, Y. E., Baek, J. Y., Ys, K., Kang, J., et al. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.07.006 · Cited by 77 · see citing works

Microbiologic Characteristics, Serologic Responses, and Clinical Manifestations in Severe Acute Respiratory Syndrome, Taiwan1

Hsueh, P., Hsiao, C.-H., Yeh, S., Wang, W., Chen, P., Wang, J., Chang, S.-C., Kao, C., & Yang, P. (2003) · Emerging infectious diseases · doi:10.3201/eid0909.030367 · Cited by 73 · see citing works

Global Spatio-temporal Patterns of Influenza in the Post-pandemic Era

He, D., Lui, R., Wang, L., Tse, C. K., Yang, L., & Stone, L. (2015) · Scientific Reports · doi:10.1038/srep11013 · Cited by 73 · see citing works

Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients

Cao, Z., Liu, L., Du, L., Zhang, C., Jiang, S., Li, T., & He, Y. (2010) · Virology Journal · doi:10.1186/1743-422x-7-299 · Cited by 72 · see citing works

Community-wide Outbreak of Infection with a 229E-like Coronavirus in Tecumseh, Michigan

Cavallaro, J. J., & Monto, A. S. (1970) · The Journal of Infectious Diseases · doi:10.1093/infdis/122.4.272 · Cited by 72 · see citing works

Serology of Severe Acute Respiratory Syndrome: Implications for Surveillance and Outcome

Chen, X., Zhou, B., Li, M., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/380397 · Cited by 71 · see citing works

Long-Term Persistence of Robust Antibody and Cytotoxic T Cell Responses in Recovered Patients Infected with SARS Coronavirus

Li, T., Xie, J., He, Y., Fan, H., Baril, L., Qiu, Z., Han, Y., Xu, W.-B., Zhang, W., You, H., et al. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000024 · Cited by 69 · see citing works

Impacts of Zika emergence in Latin America on endemic dengue transmission

Borchering, R. K., Huang, A. T., Mier-y-Terán-Romero, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13628-x · Cited by 68 · see citing works

Age‐specific prevalence of complement‐fixing antibodies to sixteen viral antigens: A computer analysis of 58,500 patients covering a period of eight years

Ukkonen, P., Hovi, T., von Bonsdorff, C., et al. (1984) · Journal of Medical Virology · doi:10.1002/jmv.1890130204 · Cited by 68 · see citing works

Seroepidemiology of group I human coronaviruses in children

Shao, X., Guo, X., Esper, F. P., Weibel, C., & Kahn, J. S. (2007) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.08.007 · Cited by 67 · see citing works

Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity

Lin, Y.-S., Lin, C., Fang, Y. T., et al. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02864.x · Cited by 64 · see citing works

Long‐Term Care Facilities: A Cornucopia of Viral Pathogens

Falsey, A. R., Dallal, G. E., Formica, M. A., et al. (2008) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.01775.x · Cited by 61 · see citing works

Enzyme-linked immunosorbent assay for detection of antibody in volunteers experimentally infected with human coronavirus strain 229 E

Kraaijeveld, C. A., Reed, S. E., & Macnaughton, M. R. (1980) · Journal of Clinical Microbiology · doi:10.1128/jcm.12.4.493-497.1980 · Cited by 59 · see citing works

Natural Mutations in the Receptor Binding Domain of Spike Glycoprotein Determine the Reactivity of Cross-Neutralization between Palm Civet Coronavirus and Severe Acute Respiratory Syndrome Coronavirus

Liu, L., Fang, Q., Dèng, F., Wang, H., Yi, C. E., Ba, L., Yu, W., Lin, R. D., Li, T., Hú, Z., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02389-06 · Cited by 57 · see citing works

The effect of intranasal nedocromil sodium on viral upper respiratory tract infections in human volunteers

Barrow, G. I., Higgins, P. G., Al‐Nakib, W., et al. (1990) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1990.tb02774.x · Cited by 50 · see citing works

RISES IN TITERS OF ANTIBODY TO HUMAN CORONA VIRUSES OC43 AND 229E IN SEATTLE FAMILIES DURING 1975–1979

Schmidt, O. W., ALLAN, I. D., Cooney, M. K., Foy, H. M., & Fox, J. P. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114315 · Cited by 49 · see citing works

Antibody against nucleocapsid protein predicts susceptibility to human coronavirus infection

Gao, X., Zhou, H., Wu, C., et al. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.07.002 · Cited by 49 · see citing works

Coronavirus isolates SK and SD from multiple sclerosis patients are serologically related to murine coronaviruses A59 and JHM and human coronavirus OC43, but not to human coronavirus 229E

Gerdes, J. C., Klein, I., DeVald, B. L., et al. (1981) · Journal of Virology · doi:10.1128/jvi.38.1.231-238.1981 · Cited by 46 · see citing works

Two-Way Antigenic Cross-Reactivity between Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Group 1 Animal CoVs Is Mediated through an Antigenic Site in the N-Terminal Region of the SARS-CoV Nucleoprotein

Vlasova, A. N., Zhang, X., Hasöksüz, M., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01169-07 · Cited by 44 · see citing works

Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients

Shi, Y., Zhuoyue, W., Li, L., Li, P., Li, C., Ma, Q., & Cao, C. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.05.006 · Cited by 43 · see citing works

Cross-Protection against a Human Enteric Coronavirus and a Virulent Bovine Enteric Coronavirus in Gnotobiotic Calves

Han, M. G., Cheon, D., Zhang, X., & Saif, L. J. (2006) · Journal of Virology · doi:10.1128/jvi.00402-06 · Cited by 43 · see citing works

Development and Evaluation of a Multiplexed Immunoassay for Simultaneous Detection of Serum IgG Antibodies to Six Human Coronaviruses

Trivedi, S. U., Miao, C., Sanchez, J. E., Caidi, H., Tamin, A., Haynes, L. M., & Thornburg, N. J. (2019) · Scientific Reports · doi:10.1038/s41598-018-37747-5 · Cited by 42 · see citing works

Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Infection in Camel Workers in Qatar During 2013–2014: A Case-Control Study

Sikkema, R. S., Farag, E., Himatt, S. M., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix174 · Cited by 40 · see citing works

Evaluation of Inapparent Nosocomial Severe Acute Respiratory Syndrome Coronavirus Infection in Vietnam by Use of Highly Specific Recombinant Truncated Nucleocapsid Protein-Based Enzyme-Linked Immunosorbent Assay

Yu, F., Le, M. Q., Inoue, S., et al. (2005) · Clinical and Vaccine Immunology · doi:10.1128/cdli.12.7.848-854.2005 · Cited by 39 · see citing works

Antibody to virus components in volunteers experimentally infected with human coronavirus 229E group viruses

Macnaughton, M. R., Hasony, H. J., Madge, M. H., & Reed, S. E. (1981) · Infection and Immunity · doi:10.1128/iai.31.3.845-849.1981 · Cited by 36 · see citing works

Specific epitopes of the structural and hypothetical proteins elicit variable humoral responses in SARS patients

Chow, S. C. S., Ho, C. Y. S., Tam, T., Wu, C. F., Cheung, T. T., Chan, P. K. S., Ng, M. H. L., Hui, P. K., Ng, H., Au, D. M. Y., et al. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.029868 · Cited by 36 · see citing works

Longitudinal profiles of immunoglobulin G antibodies against severe acute respiratory syndrome coronavirus components and neutralizing activities in recovered patients

Liu, L., Xie, J., Jianpin, S., Han, Y., Zhang, C., Fan, H., Liu, Z., Qiu, Z., He, Y., & Li, T. (2011) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548.2011.560184 · Cited by 36 · see citing works

Annexin A2 on lung epithelial cell surface is recognized by severe acute respiratory syndrome-associated coronavirus spike domain 2 antibodies

Fang, Y.-T., Lin, C., Liao, P., Kuo, Y., Wang, S., Yeh, T., Shieh, C.-C. K., Su, I., Lei, H.-Y., & Lin, Y.-S. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.11.019 · Cited by 35 · see citing works

Transmissibility of MERS-CoV Infection in Closed Setting, Riyadh, Saudi Arabia, 2015

Kerkhove, M. D. V., Alaswad, S., Assiri, A. M., Perera, R. A. P. M., Peiris, M. J. S., Bushra, H. E. E., & BinSaeed, A. A. (2019) · Emerging infectious diseases · doi:10.3201/eid2510.190130 · Cited by 34 · see citing works

Two antigenic groups of human coronaviruses detected by using enzyme-linked immunosorbent assay

Macnaughton, M. R., Madge, M. H., & Reed, S. E. (1981) · Infection and Immunity · doi:10.1128/iai.33.3.734-737.1981 · Cited by 34 · see citing works

OC43 strain‐related coronavirus antibodies in different age groups

Hovi, T., Kainulainen, H., Ziola, B. R., & Salmi, A. A. (1979) · Journal of Medical Virology · doi:10.1002/jmv.1890030410 · Cited by 34 · see citing works

Use of Antibody Avidity Assays for Diagnosis of Severe Acute Respiratory Syndrome Coronavirus Infection

Chan, K. H., Sonnenberg, K., Niedrig, M., et al. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00056-07 · Cited by 32 · see citing works

Immunoreactivity characterisation of the three structural regions of the human coronavirus OC43 nucleocapsid protein by Western blot: Implications for the diagnosis of coronavirus infection

Liang, F.-Y., Lin, L.-C., Ying, T., et al. (2012) · Journal of Virological Methods · doi:10.1016/j.jviromet.2012.11.009 · Cited by 32 · see citing works

Risk Factors for MERS-CoV Seropositivity among Animal Market and Slaughterhouse Workers, Abu Dhabi, United Arab Emirates, 2014–2017

Khudhair, A., Killerby, M. E., Mulla, M. A., Elkheir, K. A., Ternanni, W., Bandar, Z. A., Weber, S., Khoury, M., Donnelly, G., Muhairi, S. A., et al. (2019) · Emerging infectious diseases · doi:10.3201/eid2505.181728 · Cited by 29 · see citing works

Antigenic Relationship between Human Coronavirus Strain DC 43 and Hemagglutinating Encephalomyelitis Virus Strain 67N of Swine: Antibody Responses in Human and Animal Sera

Kaye, H. S., Yarbrough, W. B., Reed, C. J., et al. (1977) · The Journal of Infectious Diseases · doi:10.1093/infdis/135.2.201 · Cited by 29 · see citing works

A line immunoassay utilizing recombinant nucleocapsid proteins for detection of antibodies to human coronaviruses

Lehmann, C., Wolf, H. J., Xu, J., Zhao, Q., Shao, Y., Motz, M., & Lindner, P. (2008) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.12.002 · Cited by 28 · see citing works

Seroprevalence of MERS-CoV in healthy adults in western Saudi Arabia, 2011–2016

Degnah, A. A., Alamri, S. S., Hassan, A. M., et al. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.01.001 · Cited by 27 · see citing works

Detection of Coronavirus 229E Antibody by Indirect Hemagglutination

Kaye, H. S., Ong, S. B., & Dowdle, W. R. (1972) · Applied Microbiology · doi:10.1128/am.24.5.703-707.1972 · Cited by 27 · see citing works

Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC

Du, L., Ma, C., & Jiang, S. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.05.002 · Cited by 24 · see citing works

Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11

Cheng, M. W., Chan, C. W. L., Cheung, R. C. F., Bikkavilli, R. K., Zhao, Q., Au, S. W. N., Chan, P. K. S., Lee, S. S. T., Cheng, G. Y.-M., Ho, W. K. K., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.088 · Cited by 23 · see citing works

Recombinant protein‐based ELISA and immuno‐cytochemical assay for the diagnosis of SARS

Carattoli, A., Bonito, P. D., Grasso, F., et al. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20338 · Cited by 23 · see citing works

Comparison of Immunoglobulin G Responses to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory Syndrome (SARS) Coronavirus in Patients with SARS

Zhao, J., Wang, W., Wang, W., et al. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00432-06 · Cited by 22 · see citing works

Recombinant Truncated Nucleocapsid Protein as Antigen in a Novel Immunoglobulin M Capture Enzyme-Linked Immunosorbent Assay for Diagnosis of Severe Acute Respiratory Syndrome Coronavirus Infection

Yu, F., Le, M. Q., Inoue, S., et al. (2007) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00360-06 · Cited by 22 · see citing works

Children’s vaccines do not induce cross reactivity against SARS-CoV

Yu, Y., Jin, H., Chen, Z., et al. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.038893 · Cited by 21 · see citing works

Kinetics of Severe Acute Respiratory Syndrome (SARS) Coronavirus-Specific Antibodies in 271 Laboratory-Confirmed Cases of SARS

He, Z., Dong, Q., Zhuang, H., et al. (2004) · Clinical and Vaccine Immunology · doi:10.1128/cdli.11.4.792-794.2004 · Cited by 18 · see citing works

Serologic Follow-up of Middle East Respiratory Syndrome Coronavirus Cases and Contacts—Abu Dhabi, United Arab Emirates

Hosani, F. I. A., Kim, L., Khudhair, A., Pham, H., Mulla, M. A., Bandar, Z. A., Pradeep, K., Elkheir, K. A., Weber, S., Khoury, M., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy503 · Cited by 18 · see citing works

False positive antibody results against human T‐cell lymphotropic virus in patients with severe acute respiratory syndrome

Tsao, K., Chen, G., Huang, C., et al. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20460 · Cited by 16 · see citing works

A Strategy for Searching Antigenic Regions in the SARS-CoV Spike Protein

Ren, Y., Zhou, Z., Liu, J., et al. (2003) · Genomics Proteomics & Bioinformatics · doi:10.1016/s1672-0229(03)01026-x · Cited by 15 · see citing works

Determining SARS sub-clinical infection: A longitudinal seroepidemiological study in recovered SARS patients and controls after an outbreak in a general hospital

Yang, Z., Wang, S., Li, Q., et al. (2009) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540902919384 · Cited by 15 · see citing works

Antigenic Relatedness of Human Enteric Coronavirus Strains to Human Coronavirus OC43: A Preliminary Report

Gerna, G., Passarani, N., Cereda, P. M., et al. (1984) · The Journal of Infectious Diseases · doi:10.1093/infdis/150.4.618 · Cited by 15 · see citing works

Development and evaluation of an enzyme-linked immunosorbent assay for detection of antibodies against the spike protein of SARS-coronavirus

Zhao, J., Wang, W., Wang, G.-F., et al. (2004) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.09.024 · Cited by 13 · see citing works

Serological Study of An Imported Case of Middle East Respiratory Syndrome and His Close Contacts in China, 2015.

Wang, W. L., Wang, H. J., Deng, Y. L., et al. (2016) · PubMed Central · doi:10.3967/bes2016.027 · Cited by 12 · see citing works

The burning building

Godlee, F. (2020) · BMJ · doi:10.1136/bmj.m1101 · Cited by 10 · see citing works

The expression and antigenicity of a truncated spike-nucleocapsid fusion protein of severe acute respiratory syndrome-associated coronavirus

Mu, F., Niu, D., Mu, J., et al. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-207 · Cited by 10 · see citing works

Human LINE1 endonuclease domain as a putative target of SARS-associated autoantibodies involved in the pathogenesis of severe acute respiratory syndrome

Wei-ping, H. E., Shu, C.-L., Bo-an, L. I., et al. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200804010-00007 · Cited by 10 · see citing works

A two year serological surveillance of coronavirus infections in Hamburg

Ehrengut, W., & Sarateanu, D. E. (1980) · Infection · doi:10.1007/bf01639150 · Cited by 8 · see citing works

Natural Course of Severe Acute Respiratory Syndrome–Associated Coronavirus Immunoglobulin after Infection

Tso, E. Y. K., Tsang, O. T. Y., Lam, B. H. S., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/424573 · Cited by 7 · see citing works

Establishment of a reference panel for the detection of anti-SARS-CoV antibodies

Liu, C., Li, X., Zhang, C., et al. (2007) · Biologicals · doi:10.1016/j.biologicals.2006.11.001 · Cited by 5 · see citing works

[Development of monoclonal antibodies against SARS-CoV and identification of antigenic epitopes].

Zhou, Y., Hua, R.-H., Wang, Y., et al. (2005) · PubMed · Cited by 4 · see citing works

Potential cross-reactivity of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid (N)-based IgG ELISA assay for plasma samples from HIV-1 positive intravenous drug users (IDUs).

Yasmon, A., Ibrahim, F., Bela, B., et al. (2012) · PubMed · Cited by 4 · see citing works

A serological assay to detect SARS-CoV-2 seroconversion in humans

Amanat, F., Stadlbauer, D., Strohmeier, S., Nguyen, T. H. O., Chromikova, V., McMahon, M., Jiang, K., Arunkumar, G. A., Jurczyszak, D., Polanco, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0913-5 · Cited by 1,769 · see citing works

Age-specific mortality and immunity patterns of SARS-CoV-2

O’Driscoll, M., Ribeiro Dos Santos, G., Wang, L., Cummings, D. A. T., Azman, A. S., Paireau, J., Fontanet, A., Cauchemez, S., & Salje, H. (2021) · Nature · doi:10.1038/s41586-020-2918-0 · Cited by 1,210 · see citing works

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months

Wajnberg, A., Amanat, F., Firpo, A., Altman, D. R., Bailey, M. J., Mansour, M., McMahon, M., Meade, P., Mendu, D. R., Muellers, K., et al. (2020) · Science · doi:10.1126/science.abd7728 · Cited by 1,195 · see citing works

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)

Hall, V. J., Foulkes, S., Charlett, A., Atti, A., Monk, E. J. M., Simmons, R., Wellington, E., Cole, M. J., Saei, A., Oguti, B., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00675-9 · Cited by 638 · see citing works

Immune response, inflammation, and the clinical spectrum of COVID-19

García, L. F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01441 · Cited by 739 · see citing works

Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study

Hansen, C. H., Michlmayr, D., Gubbels, S. M., Mølbak, K., & Ethelberg, S. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00575-4 · Cited by 586 · see citing works

Immunological mechanisms of vaccine-induced protection against COVID-19 in humans

Sadarangani, M., Marchant, A., & Kollmann, T. R. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00578-z · Cited by 560 · see citing works

Germinal Center and Extrafollicular B Cell Responses in Vaccination, Immunity, and Autoimmunity

Elsner, R. A., & Shlomchik, M. J. (2020) · Immunity · doi:10.1016/j.immuni.2020.11.006 · Cited by 526 · see citing works

Immunological characteristics govern the transition of COVID-19 to endemicity

Lavine, J. S., Bjornstad, O. N., & Antia, R. (2021) · Science · doi:10.1126/science.abe6522 · Cited by 416 · see citing works

COVID-19 vaccines: The status and perspectives in delivery points of view

Chung, J. Y., Thone, M. N., & Kwon, Y. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.011 · Cited by 375 · see citing works

Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors

Uyoga, S., Adetifa, I. M. O., Karanja, H. K., Nyagwange, J., Tuju, J., Wanjiku, P., Aman, R., Mwangangi, M., Amoth, P., Kasera, K., et al. (2021) · Science · doi:10.1126/science.abe1916 · Cited by 328 · see citing works

Maturation and persistence of the anti-SARS-CoV-2 memory B cell response

Sokal, A., Chappert, P., Barba-Spaeth, G., Roeser, A., Fourati, S., Azzaoui, I., Vandenberghe, A., Fernandez, I., Meola, A., Bouvier-Alias, M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.050 · Cited by 340 · see citing works

A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation

Muruato, A. E., Fontes-Garfias, C. R., Ren, P., Garcia-Blanco, M. A., Menachery, V. D., Xie, X., & Shi, P.-Y. (2020) · Nature Communications · doi:10.1038/s41467-020-17892-0 · Cited by 319 · see citing works

Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19

Alon, R., Sportiello, M., Kozlovski, S., Kumar, A., Reilly, E. C., Zarbock, A., Garbi, N., & Topham, D. J. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00470-2 · Cited by 197 · see citing works

Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans

Vanshylla, K., Di Cristanziano, V., Kleipass, F., Dewald, F., Schommers, P., Gieselmann, L., Gruell, H., Schlotz, M., Ercanoglu, M. S., Stumpf, R., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.04.015 · Cited by 153 · see citing works

SARS-CoV-2-specific T cells in infection and vaccination

Bertoletti, A., Le Bert, N., Qui, M., & Tan, A. T. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00743-3 · Cited by 159 · see citing works

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay

Peluso, M. J., Takahashi, S., Hakim, J., Kelly, J. D., Torres, L., Iyer, N. S., Turcios, K., Janson, O., Munter, S. E., Thanh, C., et al. (2021) · Science Advances · doi:10.1126/sciadv.abh3409 · Cited by 130 · see citing works

Cross-reactive serum and memory B cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection

Song, G., He, W.-T., Callaghan, S., Anzanello, F., Huang, D., Ricketts, J., Torres, J. L., Beutler, N., Peng, L., Vargas, S., et al. (2020) · doi:10.1101/2020.09.22.308965 · Cited by 285 · see citing works

Antibody Responses to SARS-CoV-2: Let’s Stick to Known Knowns

Baumgarth, N., Nikolich-Žugich, J., Lee, F. E.-H., & Bhattacharya, D. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.2000839 · Cited by 84 · see citing works

Advancements and Challenges in Stem Cell Transplantation for Regenerative Medicine

Wei, L., Yan, W., Shah, W., Zhang, Z., Wang, M., Liu, B., Xue, Z., Cao, Y., Hou, X., Zhang, K., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35836 · Cited by 79 · see citing works

Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection

Abayasingam, A., Balachandran, H., Agapiou, D., Hammoud, M., Rodrigo, C., Keoshkerian, E., Li, H., Brasher, N. A., Christ, D., Rouet, R., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100228 · Cited by 78 · see citing works

Herd immunity by infection is not an option

Sridhar, D., & Gurdasani, D. (2021) · Science · doi:10.1126/science.abf7921 · Cited by 60 · see citing works

SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021

Mandolo, J., Msefula, J., Henrion, M. Y. R., Brown, C., Moyo, B., Samon, A., Moyo-Gwete, T., Makhado, Z., Ayres, F., Motlou, T., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02187-y · Cited by 61 · see citing works

Anti-SARS-CoV-2 Antibodies Persist for up to 13 Months and Reduce Risk of Reinfection

Gallais, F., Gantner, P., Bruel, T., Velay, A., Planas, D., Wendling, M.-J., Bayer, S., Solis, M., Laugel, E., Reix, N., et al. (2021) · doi:10.1101/2021.05.07.21256823 · Cited by 240 · see citing works

Decay of Fc-dependent antibody functions after mild to moderate COVID-19

Lee, W. S., Selva, K. J., Davis, S. K., Wines, B. D., Reynaldi, A., Esterbauer, R., Kelly, H. G., Haycroft, E. R., Tan, H.-X., Juno, J. A., et al. (2020) · doi:10.1101/2020.12.13.20248143 · Cited by 80 · see citing works